Qing Xiao
About Qing Xiao
Qing Xiao is a Principle Scientist at Bristol Myers Squibb in Cambridge, Massachusetts, with expertise in Analytical Chemistry and Chemical Physics.
Title
Qing Xiao holds the position of Principle Scientist at Bristol Myers Squibb, located in Cambridge, Massachusetts, United States.
Education and Expertise
Qing Xiao attained a Master of Science (MS) in Analytical Chemistry from the University of Nebraska-Lincoln, where he studied from 1998 to 2001. Prior to this, he earned a Bachelor's degree in Chemical Physics from the University of Science and Technology of China, completing his studies from 1991 to 1996.
Discoveries
Qing Xiao discovered citrullinated proteins as novel pharmacodynamic markers, a notable finding that enabled the selection of drug candidates in vivo and informed human dose projections.
Research and Development
Qing Xiao has conducted extensive tissue biopsy and biofluid biomarker studies for target identification, translation, early development, and clinical research across various medical fields including heart failure, cancer resistance, inflammatory bowel disease (IBD), fibrosis, and hematology.
Technological Contributions
Qing Xiao specializes in ultra-low input post-translational modification (PTM) profiling, extracellular vesicle proteomics, and phosphoproteomics in patient-derived organoids. Additionally, he leads high throughput proteome-wide neo-substrate screens for protein degrader compounds.
Innovation and Collaboration
Qing Xiao leverages external innovation to develop new reagents, workflows, data analytics, and instrumentation. He collaborates with internal Informatics and Research IT teams to drive process automation, AWS data warehousing, and infrastructure development.
Leadership and Management
As a Principle Scientist, Qing Xiao manages and trains scientists while overseeing lab operations, ensuring that his team operates efficiently and effectively.